Health ministry decides against including Itolizumab in clinical management protocols for COVID-19 Read more
DCGI queries pharma company on its claim of FabiFlu use for COVID-19 patients with comorbidities Read more
CDSCO extends consent to import drugs with less than 60 per cent residual shelf life by three months Read more